This research report focuses on the Peptide Manufacturing and Development Services Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.
TABLE OF CONTENTS
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Peptide Manufacturing and Development Services Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
- 1.2.2 GMP Services
- 1.2.3 Non-GMP Services
- 1.3 Market by Application
- 1.3.1 Global Peptide Manufacturing and Development Services Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
- 1.3.2 Commercial Production
- 1.3.3 Scientific Research
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Peptide Manufacturing and Development Services Market Perspective (2018-2029)
- 2.2 Global Peptide Manufacturing and Development Services Growth Trends by Region
- 2.2.1 Peptide Manufacturing and Development Services Market Size by Region: 2018 VS 2022 VS 2029
- 2.2.2 Peptide Manufacturing and Development Services Historic Market Size by Region (2018-2023)
- 2.2.3 Peptide Manufacturing and Development Services Forecasted Market Size by Region (2024-2029)
- 2.3 Peptide Manufacturing and Development Services Market Dynamics
- 2.3.1 Peptide Manufacturing and Development Services Industry Trends
- 2.3.2 Peptide Manufacturing and Development Services Market Drivers
- 2.3.3 Peptide Manufacturing and Development Services Market Challenges
- 2.3.4 Peptide Manufacturing and Development Services Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Revenue Peptide Manufacturing and Development Services by Players
- 3.1.1 Global Peptide Manufacturing and Development Services Revenue by Players (2018-2023)
- 3.1.2 Global Peptide Manufacturing and Development Services Revenue Market Share by Players (2018-2023)
- 3.2 Global Peptide Manufacturing and Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Global Key Players of Peptide Manufacturing and Development Services, Ranking by Revenue, 2021 VS 2022 VS 2023
- 3.4 Global Peptide Manufacturing and Development Services Market Concentration Ratio
- 3.4.1 Global Peptide Manufacturing and Development Services Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Peptide Manufacturing and Development Services Revenue in 2022
- 3.5 Global Key Players of Peptide Manufacturing and Development Services Head office and Area Served
- 3.6 Global Key Players of Peptide Manufacturing and Development Services, Product and Application
- 3.7 Global Key Players of Peptide Manufacturing and Development Services, Date of Enter into This Industry
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Manufacturing and Development Services Breakdown Data by Type
- 4.1 Global Peptide Manufacturing and Development Services Historic Market Size by Type (2018-2023)
- 4.2 Global Peptide Manufacturing and Development Services Forecasted Market Size by Type (2024-2029)
5 Peptide Manufacturing and Development Services Breakdown Data by Application
- 5.1 Global Peptide Manufacturing and Development Services Historic Market Size by Application (2018-2023)
- 5.2 Global Peptide Manufacturing and Development Services Forecasted Market Size by Application (2024-2029)
6 North America
- 6.1 North America Peptide Manufacturing and Development Services Market Size (2018-2029)
- 6.2 North America Peptide Manufacturing and Development Services Market Size by Type
- 6.2.1 North America Peptide Manufacturing and Development Services Market Size by Type (2018-2023)
- 6.2.2 North America Peptide Manufacturing and Development Services Market Size by Type (2024-2029)
- 6.2.3 North America Peptide Manufacturing and Development Services Market Share by Type (2018-2029)
- 6.3 North America Peptide Manufacturing and Development Services Market Size by Application
- 6.3.1 North America Peptide Manufacturing and Development Services Market Size by Application (2018-2023)
- 6.3.2 North America Peptide Manufacturing and Development Services Market Size by Application (2024-2029)
- 6.3.3 North America Peptide Manufacturing and Development Services Market Share by Application (2018-2029)
- 6.4 North America Peptide Manufacturing and Development Services Market Size by Country
- 6.4.1 North America Peptide Manufacturing and Development Services Market Size by Country: 2018 VS 2022 VS 2029
- 6.4.2 North America Peptide Manufacturing and Development Services Market Size by Country (2018-2023)
- 6.4.3 North America Peptide Manufacturing and Development Services Market Size by Country (2024-2029)
- 6.4.4 United States
- 6.4.5 Canada
7 Europe
- 7.1 Europe Peptide Manufacturing and Development Services Market Size (2018-2029)
- 7.2 Europe Peptide Manufacturing and Development Services Market Size by Type
- 7.2.1 Europe Peptide Manufacturing and Development Services Market Size by Type (2018-2023)
- 7.2.2 Europe Peptide Manufacturing and Development Services Market Size by Type (2024-2029)
- 7.2.3 Europe Peptide Manufacturing and Development Services Market Share by Type (2018-2029)
- 7.3 Europe Peptide Manufacturing and Development Services Market Size by Application
- 7.3.1 Europe Peptide Manufacturing and Development Services Market Size by Application (2018-2023)
- 7.3.2 Europe Peptide Manufacturing and Development Services Market Size by Application (2024-2029)
- 7.3.3 Europe Peptide Manufacturing and Development Services Market Share by Application (2018-2029)
- 7.4 Europe Peptide Manufacturing and Development Services Market Size by Country
- 7.4.1 Europe Peptide Manufacturing and Development Services Market Size by Country: 2018 VS 2022 VS 2029
- 7.4.2 Europe Peptide Manufacturing and Development Services Market Size by Country (2018-2023)
- 7.4.3 Europe Peptide Manufacturing and Development Services Market Size by Country (2024-2029)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries
8 China
- 8.1 China Peptide Manufacturing and Development Services Market Size (2018-2029)
- 8.2 China Peptide Manufacturing and Development Services Market Size by Type
- 8.2.1 China Peptide Manufacturing and Development Services Market Size by Type (2018-2023)
- 8.2.2 China Peptide Manufacturing and Development Services Market Size by Type (2024-2029)
- 8.2.3 China Peptide Manufacturing and Development Services Market Share by Type (2018-2029)
- 8.3 China Peptide Manufacturing and Development Services Market Size by Application
- 8.3.1 China Peptide Manufacturing and Development Services Market Size by Application (2018-2023)
- 8.3.2 China Peptide Manufacturing and Development Services Market Size by Application (2024-2029)
- 8.3.3 China Peptide Manufacturing and Development Services Market Share by Application (2018-2029)
9 Asia (excluding China)
- 9.1 Asia Peptide Manufacturing and Development Services Market Size (2018-2029)
- 9.2 Asia Peptide Manufacturing and Development Services Market Size by Type
- 9.2.1 Asia Peptide Manufacturing and Development Services Market Size by Type (2018-2023)
- 9.2.2 Asia Peptide Manufacturing and Development Services Market Size by Type (2024-2029)
- 9.2.3 Asia Peptide Manufacturing and Development Services Market Share by Type (2018-2029)
- 9.3 Asia Peptide Manufacturing and Development Services Market Size by Application
- 9.3.1 Asia Peptide Manufacturing and Development Services Market Size by Application (2018-2023)
- 9.3.2 Asia Peptide Manufacturing and Development Services Market Size by Application (2024-2029)
- 9.3.3 Asia Peptide Manufacturing and Development Services Market Share by Application (2018-2029)
- 9.4 Asia Peptide Manufacturing and Development Services Market Size by Region
- 9.4.1 Asia Peptide Manufacturing and Development Services Market Size by Region: 2018 VS 2022 VS 2029
- 9.4.2 Asia Peptide Manufacturing and Development Services Market Size by Region (2018-2023)
- 9.4.3 Asia Peptide Manufacturing and Development Services Market Size by Region (2024-2029)
- 9.4.4 Japan
- 9.4.5 South Korea
- 9.4.6 China Taiwan
- 9.4.7 Southeast Asia
- 9.4.8 India
- 9.4.9 Australia
10 Middle East, Africa, and Latin America
- 10.1 Middle East, Africa, and Latin America Peptide Manufacturing and Development Services Market Size (2018-2029)
- 10.2 Middle East, Africa, and Latin America Peptide Manufacturing and Development Services Market Size by Type
- 10.2.1 Middle East, Africa, and Latin America Peptide Manufacturing and Development Services Market Size by Type (2018-2023)
- 10.2.2 Middle East, Africa, and Latin America Peptide Manufacturing and Development Services Market Size by Type (2024-2029)
- 10.2.3 Middle East, Africa, and Latin America Peptide Manufacturing and Development Services Market Share by Type (2018-2029)
- 10.3 Middle East, Africa, and Latin America Peptide Manufacturing and Development Services Market Size by Application
- 10.3.1 Middle East, Africa, and Latin America Peptide Manufacturing and Development Services Market Size by Application (2018-2023)
- 10.3.2 Middle East, Africa, and Latin America Peptide Manufacturing and Development Services Market Size by Application (2024-2029)
- 10.3.3 Middle East, Africa, and Latin America Peptide Manufacturing and Development Services Market Share by Application (2018-2029)
- 10.4 Middle East, Africa, and Latin America Peptide Manufacturing and Development Services Market Size by Country
- 10.4.1 Middle East, Africa, and Latin America Peptide Manufacturing and Development Services Market Size by Country: 2018 VS 2022 VS 2029
- 10.4.2 Middle East, Africa, and Latin America Peptide Manufacturing and Development Services Market Size by Country (2018-2023)
- 10.4.3 Middle East, Africa, and Latin America Peptide Manufacturing and Development Services Market Size by Country (2024-2029)
- 10.4.4 Brazil
- 10.4.5 Mexico
- 10.4.6 Turkey
- 10.4.7 Saudi Arabia
- 10.4.8 Israel
- 10.4.9 GCC Countries
11 Key Players Profiles
- 11.1 Bachem
- 11.1.1 Bachem Company Details
- 11.1.2 Bachem Business Overview
- 11.1.3 Bachem Peptide Manufacturing and Development Services Introduction
- 11.1.4 Bachem Revenue in Peptide Manufacturing and Development Services Business (2018-2023)
- 11.1.5 Bachem Recent Developments
- 11.2 PolyPeptide
- 11.2.1 PolyPeptide Company Details
- 11.2.2 PolyPeptide Business Overview
- 11.2.3 PolyPeptide Peptide Manufacturing and Development Services Introduction
- 11.2.4 PolyPeptide Revenue in Peptide Manufacturing and Development Services Business (2018-2023)
- 11.2.5 PolyPeptide Recent Developments
- 11.3 CordenPharma
- 11.3.1 CordenPharma Company Details
- 11.3.2 CordenPharma Business Overview
- 11.3.3 CordenPharma Peptide Manufacturing and Development Services Introduction
- 11.3.4 CordenPharma Revenue in Peptide Manufacturing and Development Services Business (2018-2023)
- 11.3.5 CordenPharma Recent Developments
- 11.4 AmbioPharm
- 11.4.1 AmbioPharm Company Details
- 11.4.2 AmbioPharm Business Overview
- 11.4.3 AmbioPharm Peptide Manufacturing and Development Services Introduction
- 11.4.4 AmbioPharm Revenue in Peptide Manufacturing and Development Services Business (2018-2023)
- 11.4.5 AmbioPharm Recent Developments
- 11.5 USV Peptides
- 11.5.1 USV Peptides Company Details
- 11.5.2 USV Peptides Business Overview
- 11.5.3 USV Peptides Peptide Manufacturing and Development Services Introduction
- 11.5.4 USV Peptides Revenue in Peptide Manufacturing and Development Services Business (2018-2023)
- 11.5.5 USV Peptides Recent Developments
- 11.6 Thermofischer
- 11.6.1 Thermofischer Company Details
- 11.6.2 Thermofischer Business Overview
- 11.6.3 Thermofischer Peptide Manufacturing and Development Services Introduction
- 11.6.4 Thermofischer Revenue in Peptide Manufacturing and Development Services Business (2018-2023)
- 11.6.5 Thermofischer Recent Developments
- 11.7 Bio Basic
- 11.7.1 Bio Basic Company Details
- 11.7.2 Bio Basic Business Overview
- 11.7.3 Bio Basic Peptide Manufacturing and Development Services Introduction
- 11.7.4 Bio Basic Revenue in Peptide Manufacturing and Development Services Business (2018-2023)
- 11.7.5 Bio Basic Recent Developments
- 11.8 JPT
- 11.8.1 JPT Company Details
- 11.8.2 JPT Business Overview
- 11.8.3 JPT Peptide Manufacturing and Development Services Introduction
- 11.8.4 JPT Revenue in Peptide Manufacturing and Development Services Business (2018-2023)
- 11.8.5 JPT Recent Developments
- 11.9 Genscript
- 11.9.1 Genscript Company Details
- 11.9.2 Genscript Business Overview
- 11.9.3 Genscript Peptide Manufacturing and Development Services Introduction
- 11.9.4 Genscript Revenue in Peptide Manufacturing and Development Services Business (2018-2023)
- 11.9.5 Genscript Recent Developments
- 11.10 Xinbang Pharma
- 11.10.1 Xinbang Pharma Company Details
- 11.10.2 Xinbang Pharma Business Overview
- 11.10.3 Xinbang Pharma Peptide Manufacturing and Development Services Introduction
- 11.10.4 Xinbang Pharma Revenue in Peptide Manufacturing and Development Services Business (2018-2023)
- 11.10.5 Xinbang Pharma Recent Developments
- 11.11 ScinoPharm
- 11.11.1 ScinoPharm Company Details
- 11.11.2 ScinoPharm Business Overview
- 11.11.3 ScinoPharm Peptide Manufacturing and Development Services Introduction
- 11.11.4 ScinoPharm Revenue in Peptide Manufacturing and Development Services Business (2018-2023)
- 11.11.5 ScinoPharm Recent Developments
- 11.12 SN Biopharm
- 11.12.1 SN Biopharm Company Details
- 11.12.2 SN Biopharm Business Overview
- 11.12.3 SN Biopharm Peptide Manufacturing and Development Services Introduction
- 11.12.4 SN Biopharm Revenue in Peptide Manufacturing and Development Services Business (2018-2023)
- 11.12.5 SN Biopharm Recent Developments
- 11.13 CBL
- 11.13.1 CBL Company Details
- 11.13.2 CBL Business Overview
- 11.13.3 CBL Peptide Manufacturing and Development Services Introduction
- 11.13.4 CBL Revenue in Peptide Manufacturing and Development Services Business (2018-2023)
- 11.13.5 CBL Recent Developments
- 11.14 Piramal Pharma
- 11.14.1 Piramal Pharma Company Details
- 11.14.2 Piramal Pharma Business Overview
- 11.14.3 Piramal Pharma Peptide Manufacturing and Development Services Introduction
- 11.14.4 Piramal Pharma Revenue in Peptide Manufacturing and Development Services Business (2018-2023)
- 11.14.5 Piramal Pharma Recent Developments
- 11.15 CPC Scientific
- 11.15.1 CPC Scientific Company Details
- 11.15.2 CPC Scientific Business Overview
- 11.15.3 CPC Scientific Peptide Manufacturing and Development Services Introduction
- 11.15.4 CPC Scientific Revenue in Peptide Manufacturing and Development Services Business (2018-2023)
- 11.15.5 CPC Scientific Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
- 13.3 Author Details